Starting dose: 0.25 mg injected subcutaneously into the abdomen, thigh, or upper arm once weekly
The Ozempic prescribing information lists three indications, all in type 2 diabetes: improving glycemic control, reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease, and reducing the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with chronic kidney disease
Contraindications You should not receive MIC+B12 injections if you: Have a known allergy or hypersensitivity to any of the ingredients (e.g., methionine, inositol, choline, vitamin B12) or their preservatives
labile iron pool) are present at very low concentrations due to the metal sequestration
Other potential side effects include headaches and digestive discomfort
Discuss Dose-Related Symptoms With a Clinician Contact the prescriber if headaches repeatedly follow injections or dose increases, persist despite basic measures, or interfere with daily activities
